GreenLight Biosciences Holdings
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has GreenLight Biosciences Holdings's balance sheet done over the years? Its assets were worth $148,598,000 last year, which is more than in the previous period. 68% of GreenLight Biosciences Holdings’s total assets is currently financed by debt. Its liabilities reached the amount of $100,536,000, which means an increase by 8% compared compared to last year.

Debt to Assets

GreenLight Biosciences Holdings (NASDAQ:GRNA): Debt to assets
2019 30609000 117.23M 383%
2020 113828000 252.65M 221.96%
2021 63058000 93.03M 147.54%
2022 148598000 100.53M 67.66%

GRNA Balance Sheet (2019 – 2022)

2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
68.09M31.44M95.06M25.91M
Short term investments
0000
Net receivables
0000
Inventory
0000
Other current assets
3.21M462.55K00
Total current assets
71.31M33.77M97.09M26.46M
Non-current assets:
Property, Plant and Equipment
74.13M23.39M16.27M3.74M
Goodwill
0000
Intangible assets
0000
Long term investments
0000
Other non-current assets
3.15M5.88M450K400K
Total non-current assets
77.28M29.28M16.72M4.14M
Total assets
148.59M63.05M113.82M30.60M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
3.86M963K1.66M0
Short term debt
16.58M38.92M633K680K
Total current liabilities
35.56M62.34M13.91M5.72M
Non-current liabilities:
Long term debt
63.89M27.15M18.26M892K
Deferred tax
0000
Other non-current liabilities
1.08M3.54M220.47M110.61M
Total non-current liabilities
64.97M30.69M238.73M111.50M
Total liabilities
100.53M93.03M252.65M117.23M
Data sourceData sourceData source